DroneShield Limited (DRSHF) Stock Competitors & Peer Comparison
See (DRSHF) competitors and their performances in Stock Market.
Peer Comparison Table: Computer Hardware Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DRSHF | $2.02 | -4.27% | 1.9B | 209.00 | $0.01 | N/A |
| QUCCF | $12.25 | +0.00% | 47.2B | 10.21 | $1.20 | +18.07% |
| LNVGF | $3.01 | -2.59% | 37.2B | 21.44 | $0.14 | +1.66% |
| LNVGY | $60.03 | -4.46% | 37.2B | 21.58 | $2.78 | +1.64% |
| CAJFF | $26.87 | -1.19% | 23.8B | 11.93 | $2.30 | +3.88% |
| CAJPY | $26.86 | -2.87% | 23.3B | 11.66 | $2.30 | +3.48% |
| ASUUY | $80.00 | +0.00% | 11.9B | 8.50 | $9.41 | +7.21% |
| SEKEF | $20.20 | +0.00% | 6.5B | 20.00 | $1.01 | +2.39% |
| SEKEY | $9.05 | -4.03% | 5.8B | 50.61 | $0.18 | +2.48% |
| ACEYY | $5.14 | +0.00% | 3.1B | 34.27 | $0.15 | +5.02% |
Stock Comparison
DRSHF vs QUCCF Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, QUCCF has a market cap of 47.2B. Regarding current trading prices, DRSHF is priced at $2.02, while QUCCF trades at $12.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas QUCCF's P/E ratio is 10.21. In terms of profitability, DRSHF's ROE is +0.01%, compared to QUCCF's ROE of +0.36%. Regarding short-term risk, DRSHF is less volatile compared to QUCCF. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check QUCCF's competition here
DRSHF vs LNVGF Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, LNVGF has a market cap of 37.2B. Regarding current trading prices, DRSHF is priced at $2.02, while LNVGF trades at $3.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas LNVGF's P/E ratio is 21.44. In terms of profitability, DRSHF's ROE is +0.01%, compared to LNVGF's ROE of +0.27%. Regarding short-term risk, DRSHF is more volatile compared to LNVGF. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check LNVGF's competition here
DRSHF vs LNVGY Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, LNVGY has a market cap of 37.2B. Regarding current trading prices, DRSHF is priced at $2.02, while LNVGY trades at $60.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas LNVGY's P/E ratio is 21.58. In terms of profitability, DRSHF's ROE is +0.01%, compared to LNVGY's ROE of +0.27%. Regarding short-term risk, DRSHF is more volatile compared to LNVGY. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check LNVGY's competition here
DRSHF vs CAJFF Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, CAJFF has a market cap of 23.8B. Regarding current trading prices, DRSHF is priced at $2.02, while CAJFF trades at $26.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas CAJFF's P/E ratio is 11.93. In terms of profitability, DRSHF's ROE is +0.01%, compared to CAJFF's ROE of +0.09%. Regarding short-term risk, DRSHF is more volatile compared to CAJFF. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check CAJFF's competition here
DRSHF vs CAJPY Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, CAJPY has a market cap of 23.3B. Regarding current trading prices, DRSHF is priced at $2.02, while CAJPY trades at $26.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas CAJPY's P/E ratio is 11.66. In terms of profitability, DRSHF's ROE is +0.01%, compared to CAJPY's ROE of +0.09%. Regarding short-term risk, DRSHF is more volatile compared to CAJPY. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check CAJPY's competition here
DRSHF vs ASUUY Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, ASUUY has a market cap of 11.9B. Regarding current trading prices, DRSHF is priced at $2.02, while ASUUY trades at $80.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas ASUUY's P/E ratio is 8.50. In terms of profitability, DRSHF's ROE is +0.01%, compared to ASUUY's ROE of +0.16%. Regarding short-term risk, DRSHF is less volatile compared to ASUUY. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check ASUUY's competition here
DRSHF vs SEKEF Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, SEKEF has a market cap of 6.5B. Regarding current trading prices, DRSHF is priced at $2.02, while SEKEF trades at $20.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas SEKEF's P/E ratio is 20.00. In terms of profitability, DRSHF's ROE is +0.01%, compared to SEKEF's ROE of +0.03%. Regarding short-term risk, DRSHF is more volatile compared to SEKEF. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check SEKEF's competition here
DRSHF vs SEKEY Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, SEKEY has a market cap of 5.8B. Regarding current trading prices, DRSHF is priced at $2.02, while SEKEY trades at $9.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas SEKEY's P/E ratio is 50.61. In terms of profitability, DRSHF's ROE is +0.01%, compared to SEKEY's ROE of +0.02%. Regarding short-term risk, DRSHF is more volatile compared to SEKEY. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check SEKEY's competition here
DRSHF vs ACEYY Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, ACEYY has a market cap of 3.1B. Regarding current trading prices, DRSHF is priced at $2.02, while ACEYY trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas ACEYY's P/E ratio is 34.27. In terms of profitability, DRSHF's ROE is +0.01%, compared to ACEYY's ROE of +0.04%. Regarding short-term risk, DRSHF is more volatile compared to ACEYY. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check ACEYY's competition here
DRSHF vs LGNRF Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, LGNRF has a market cap of 2.7B. Regarding current trading prices, DRSHF is priced at $2.02, while LGNRF trades at $1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas LGNRF's P/E ratio is -4.52. In terms of profitability, DRSHF's ROE is +0.01%, compared to LGNRF's ROE of +0.02%. Regarding short-term risk, DRSHF is less volatile compared to LGNRF. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check LGNRF's competition here
DRSHF vs FXCOF Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, FXCOF has a market cap of 2.5B. Regarding current trading prices, DRSHF is priced at $2.02, while FXCOF trades at $1.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas FXCOF's P/E ratio is 17.60. In terms of profitability, DRSHF's ROE is +0.01%, compared to FXCOF's ROE of +0.03%. Regarding short-term risk, DRSHF is more volatile compared to FXCOF. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check FXCOF's competition here
DRSHF vs TSHTY Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, TSHTY has a market cap of 1.1B. Regarding current trading prices, DRSHF is priced at $2.02, while TSHTY trades at $9.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas TSHTY's P/E ratio is -76.50. In terms of profitability, DRSHF's ROE is +0.01%, compared to TSHTY's ROE of -0.03%. Regarding short-term risk, DRSHF is more volatile compared to TSHTY. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check TSHTY's competition here
DRSHF vs NLST Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, NLST has a market cap of 976.6M. Regarding current trading prices, DRSHF is priced at $2.02, while NLST trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas NLST's P/E ratio is -97.67. In terms of profitability, DRSHF's ROE is +0.01%, compared to NLST's ROE of +1.78%. Regarding short-term risk, DRSHF is more volatile compared to NLST. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check NLST's competition here
DRSHF vs WACMF Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, WACMF has a market cap of 729.3M. Regarding current trading prices, DRSHF is priced at $2.02, while WACMF trades at $5.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas WACMF's P/E ratio is 12.04. In terms of profitability, DRSHF's ROE is +0.01%, compared to WACMF's ROE of +0.28%. Regarding short-term risk, DRSHF is less volatile compared to WACMF. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check WACMF's competition here
DRSHF vs WACMY Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, WACMY has a market cap of 639.1M. Regarding current trading prices, DRSHF is priced at $2.02, while WACMY trades at $4.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas WACMY's P/E ratio is 10.80. In terms of profitability, DRSHF's ROE is +0.01%, compared to WACMY's ROE of +0.28%. Regarding short-term risk, DRSHF is more volatile compared to WACMY. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check WACMY's competition here
DRSHF vs PCPPF Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, PCPPF has a market cap of 384M. Regarding current trading prices, DRSHF is priced at $2.02, while PCPPF trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas PCPPF's P/E ratio is 8.33. In terms of profitability, DRSHF's ROE is +0.01%, compared to PCPPF's ROE of +0.16%. Regarding short-term risk, DRSHF is less volatile compared to PCPPF. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check PCPPF's competition here
DRSHF vs JFEYF Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, JFEYF has a market cap of 383.7M. Regarding current trading prices, DRSHF is priced at $2.02, while JFEYF trades at $12.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas JFEYF's P/E ratio is 14.37. In terms of profitability, DRSHF's ROE is +0.01%, compared to JFEYF's ROE of +0.12%. Regarding short-term risk, DRSHF is less volatile compared to JFEYF. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check JFEYF's competition here
DRSHF vs TAKOF Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, TAKOF has a market cap of 311.9M. Regarding current trading prices, DRSHF is priced at $2.02, while TAKOF trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas TAKOF's P/E ratio is -15.37. In terms of profitability, DRSHF's ROE is +0.01%, compared to TAKOF's ROE of -0.44%. Regarding short-term risk, DRSHF is more volatile compared to TAKOF. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check TAKOF's competition here
DRSHF vs AOMUF Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, AOMUF has a market cap of 153.8M. Regarding current trading prices, DRSHF is priced at $2.02, while AOMUF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas AOMUF's P/E ratio is -10.62. In terms of profitability, DRSHF's ROE is +0.01%, compared to AOMUF's ROE of -0.24%. Regarding short-term risk, DRSHF is more volatile compared to AOMUF. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check AOMUF's competition here
DRSHF vs FRIIF Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, FRIIF has a market cap of 78.7M. Regarding current trading prices, DRSHF is priced at $2.02, while FRIIF trades at $12.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas FRIIF's P/E ratio is 6.10. In terms of profitability, DRSHF's ROE is +0.01%, compared to FRIIF's ROE of +0.05%. Regarding short-term risk, DRSHF is more volatile compared to FRIIF. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check FRIIF's competition here
DRSHF vs XAARF Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, XAARF has a market cap of 72.4M. Regarding current trading prices, DRSHF is priced at $2.02, while XAARF trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas XAARF's P/E ratio is -5.11. In terms of profitability, DRSHF's ROE is +0.01%, compared to XAARF's ROE of -0.06%. Regarding short-term risk, DRSHF is less volatile compared to XAARF. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check XAARF's competition here
DRSHF vs TBIIF Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, TBIIF has a market cap of 66M. Regarding current trading prices, DRSHF is priced at $2.02, while TBIIF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas TBIIF's P/E ratio is -2.01. In terms of profitability, DRSHF's ROE is +0.01%, compared to TBIIF's ROE of -0.60%. Regarding short-term risk, DRSHF is less volatile compared to TBIIF. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check TBIIF's competition here
DRSHF vs CREAF Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, CREAF has a market cap of 46.6M. Regarding current trading prices, DRSHF is priced at $2.02, while CREAF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas CREAF's P/E ratio is -8.28. In terms of profitability, DRSHF's ROE is +0.01%, compared to CREAF's ROE of -0.18%. Regarding short-term risk, DRSHF is more volatile compared to CREAF. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check CREAF's competition here
DRSHF vs AOTOF Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, AOTOF has a market cap of 33.1M. Regarding current trading prices, DRSHF is priced at $2.02, while AOTOF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas AOTOF's P/E ratio is N/A. In terms of profitability, DRSHF's ROE is +0.01%, compared to AOTOF's ROE of -4.00%. Regarding short-term risk, DRSHF is more volatile compared to AOTOF. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check AOTOF's competition here
DRSHF vs EVRC Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, EVRC has a market cap of 11.4M. Regarding current trading prices, DRSHF is priced at $2.02, while EVRC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas EVRC's P/E ratio is 11.67. In terms of profitability, DRSHF's ROE is +0.01%, compared to EVRC's ROE of +0.02%. Regarding short-term risk, DRSHF is more volatile compared to EVRC. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check EVRC's competition here
DRSHF vs AITX Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, AITX has a market cap of 11M. Regarding current trading prices, DRSHF is priced at $2.02, while AITX trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas AITX's P/E ratio is -6.35. In terms of profitability, DRSHF's ROE is +0.01%, compared to AITX's ROE of +0.32%. Regarding short-term risk, DRSHF is less volatile compared to AITX. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check AITX's competition here
DRSHF vs CCUR Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, CCUR has a market cap of 6.8M. Regarding current trading prices, DRSHF is priced at $2.02, while CCUR trades at $2,310.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas CCUR's P/E ratio is -4.69. In terms of profitability, DRSHF's ROE is +0.01%, compared to CCUR's ROE of +0.22%. Regarding short-term risk, DRSHF is less volatile compared to CCUR. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check CCUR's competition here
DRSHF vs FNTTF Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, FNTTF has a market cap of 4.9M. Regarding current trading prices, DRSHF is priced at $2.02, while FNTTF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas FNTTF's P/E ratio is -1.60. In terms of profitability, DRSHF's ROE is +0.01%, compared to FNTTF's ROE of +0.89%. Regarding short-term risk, DRSHF is less volatile compared to FNTTF. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check FNTTF's competition here
DRSHF vs VRTK Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, VRTK has a market cap of 4M. Regarding current trading prices, DRSHF is priced at $2.02, while VRTK trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas VRTK's P/E ratio is 20.50. In terms of profitability, DRSHF's ROE is +0.01%, compared to VRTK's ROE of N/A. Regarding short-term risk, DRSHF is less volatile compared to VRTK. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check VRTK's competition here
DRSHF vs TKSTF Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, TKSTF has a market cap of 2M. Regarding current trading prices, DRSHF is priced at $2.02, while TKSTF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas TKSTF's P/E ratio is -4.10. In terms of profitability, DRSHF's ROE is +0.01%, compared to TKSTF's ROE of +0.06%. Regarding short-term risk, DRSHF is more volatile compared to TKSTF. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check TKSTF's competition here
DRSHF vs JLMKF Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, JLMKF has a market cap of 919.3K. Regarding current trading prices, DRSHF is priced at $2.02, while JLMKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas JLMKF's P/E ratio is -0.15. In terms of profitability, DRSHF's ROE is +0.01%, compared to JLMKF's ROE of +1.55%. Regarding short-term risk, DRSHF is less volatile compared to JLMKF. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check JLMKF's competition here
DRSHF vs CRTG Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, CRTG has a market cap of 431.7K. Regarding current trading prices, DRSHF is priced at $2.02, while CRTG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas CRTG's P/E ratio is -0.15. In terms of profitability, DRSHF's ROE is +0.01%, compared to CRTG's ROE of -2.38%. Regarding short-term risk, DRSHF is more volatile compared to CRTG. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check CRTG's competition here
DRSHF vs ITOX Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, ITOX has a market cap of 234.6K. Regarding current trading prices, DRSHF is priced at $2.02, while ITOX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas ITOX's P/E ratio is -0.04. In terms of profitability, DRSHF's ROE is +0.01%, compared to ITOX's ROE of +0.54%. Regarding short-term risk, DRSHF is less volatile compared to ITOX. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check ITOX's competition here
DRSHF vs DDDX Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, DDDX has a market cap of 197.6K. Regarding current trading prices, DRSHF is priced at $2.02, while DDDX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas DDDX's P/E ratio is -0.50. In terms of profitability, DRSHF's ROE is +0.01%, compared to DDDX's ROE of +0.10%. Regarding short-term risk, DRSHF is more volatile compared to DDDX. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check DDDX's competition here
DRSHF vs HAUP Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, HAUP has a market cap of 104.3K. Regarding current trading prices, DRSHF is priced at $2.02, while HAUP trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas HAUP's P/E ratio is -0.13. In terms of profitability, DRSHF's ROE is +0.01%, compared to HAUP's ROE of +92.50%. Regarding short-term risk, DRSHF is more volatile compared to HAUP. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check HAUP's competition here
DRSHF vs YRLLF Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, YRLLF has a market cap of 103.6K. Regarding current trading prices, DRSHF is priced at $2.02, while YRLLF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas YRLLF's P/E ratio is -2.10. In terms of profitability, DRSHF's ROE is +0.01%, compared to YRLLF's ROE of +0.08%. Regarding short-term risk, DRSHF is less volatile compared to YRLLF. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check YRLLF's competition here
DRSHF vs GOSY Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, GOSY has a market cap of 82.5K. Regarding current trading prices, DRSHF is priced at $2.02, while GOSY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas GOSY's P/E ratio is -0.10. In terms of profitability, DRSHF's ROE is +0.01%, compared to GOSY's ROE of -0.17%. Regarding short-term risk, DRSHF is more volatile compared to GOSY. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check GOSY's competition here
DRSHF vs EUOT Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, EUOT has a market cap of 48K. Regarding current trading prices, DRSHF is priced at $2.02, while EUOT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas EUOT's P/E ratio is N/A. In terms of profitability, DRSHF's ROE is +0.01%, compared to EUOT's ROE of +28.93%. Regarding short-term risk, DRSHF is less volatile compared to EUOT. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check EUOT's competition here
DRSHF vs RDRSF Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, RDRSF has a market cap of 17.7K. Regarding current trading prices, DRSHF is priced at $2.02, while RDRSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas RDRSF's P/E ratio is -0.01. In terms of profitability, DRSHF's ROE is +0.01%, compared to RDRSF's ROE of +2.09%. Regarding short-term risk, DRSHF is less volatile compared to RDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check RDRSF's competition here
DRSHF vs MDEA Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, MDEA has a market cap of 13.2K. Regarding current trading prices, DRSHF is priced at $2.02, while MDEA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas MDEA's P/E ratio is -0.00. In terms of profitability, DRSHF's ROE is +0.01%, compared to MDEA's ROE of -1.30%. Regarding short-term risk, DRSHF is less volatile compared to MDEA. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check MDEA's competition here
DRSHF vs SNIOF Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, SNIOF has a market cap of 11.3K. Regarding current trading prices, DRSHF is priced at $2.02, while SNIOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas SNIOF's P/E ratio is -0.00. In terms of profitability, DRSHF's ROE is +0.01%, compared to SNIOF's ROE of N/A. Regarding short-term risk, DRSHF is less volatile compared to SNIOF. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check SNIOF's competition here
DRSHF vs NADA Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, NADA has a market cap of 9.3K. Regarding current trading prices, DRSHF is priced at $2.02, while NADA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas NADA's P/E ratio is N/A. In terms of profitability, DRSHF's ROE is +0.01%, compared to NADA's ROE of -8.82%. Regarding short-term risk, DRSHF is less volatile compared to NADA. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check NADA's competition here
DRSHF vs VOIS Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, VOIS has a market cap of 8.9K. Regarding current trading prices, DRSHF is priced at $2.02, while VOIS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas VOIS's P/E ratio is N/A. In terms of profitability, DRSHF's ROE is +0.01%, compared to VOIS's ROE of +2.41%. Regarding short-term risk, DRSHF is less volatile compared to VOIS. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check VOIS's competition here
DRSHF vs VMRI Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, VMRI has a market cap of 7K. Regarding current trading prices, DRSHF is priced at $2.02, while VMRI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas VMRI's P/E ratio is N/A. In terms of profitability, DRSHF's ROE is +0.01%, compared to VMRI's ROE of -16.14%. Regarding short-term risk, DRSHF is more volatile compared to VMRI. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check VMRI's competition here
DRSHF vs CBEX Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, CBEX has a market cap of 2.4K. Regarding current trading prices, DRSHF is priced at $2.02, while CBEX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas CBEX's P/E ratio is 0.01. In terms of profitability, DRSHF's ROE is +0.01%, compared to CBEX's ROE of -0.28%. Regarding short-term risk, DRSHF is more volatile compared to CBEX. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check CBEX's competition here
DRSHF vs MCZAF Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, MCZAF has a market cap of 2.2K. Regarding current trading prices, DRSHF is priced at $2.02, while MCZAF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas MCZAF's P/E ratio is N/A. In terms of profitability, DRSHF's ROE is +0.01%, compared to MCZAF's ROE of -1.17%. Regarding short-term risk, DRSHF is less volatile compared to MCZAF. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check MCZAF's competition here
DRSHF vs VIDE Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, VIDE has a market cap of 588. Regarding current trading prices, DRSHF is priced at $2.02, while VIDE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas VIDE's P/E ratio is N/A. In terms of profitability, DRSHF's ROE is +0.01%, compared to VIDE's ROE of +0.38%. Regarding short-term risk, DRSHF is less volatile compared to VIDE. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check VIDE's competition here
DRSHF vs SOSO Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, SOSO has a market cap of 374. Regarding current trading prices, DRSHF is priced at $2.02, while SOSO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas SOSO's P/E ratio is N/A. In terms of profitability, DRSHF's ROE is +0.01%, compared to SOSO's ROE of -1.25%. Regarding short-term risk, DRSHF is less volatile compared to SOSO. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check SOSO's competition here
DRSHF vs DWDZF Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, DWDZF has a market cap of 224. Regarding current trading prices, DRSHF is priced at $2.02, while DWDZF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas DWDZF's P/E ratio is N/A. In terms of profitability, DRSHF's ROE is +0.01%, compared to DWDZF's ROE of +0.66%. Regarding short-term risk, DRSHF is less volatile compared to DWDZF. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check DWDZF's competition here
DRSHF vs ORYX Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, ORYX has a market cap of 2. Regarding current trading prices, DRSHF is priced at $2.02, while ORYX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas ORYX's P/E ratio is -0.00. In terms of profitability, DRSHF's ROE is +0.01%, compared to ORYX's ROE of -0.20%. Regarding short-term risk, DRSHF is more volatile compared to ORYX. This indicates potentially higher risk in terms of short-term price fluctuations for DRSHF.Check ORYX's competition here
DRSHF vs IWRS Comparison June 2026
DRSHF plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DRSHF stands at 1.9B. In comparison, IWRS has a market cap of 0. Regarding current trading prices, DRSHF is priced at $2.02, while IWRS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DRSHF currently has a P/E ratio of 209.00, whereas IWRS's P/E ratio is N/A. In terms of profitability, DRSHF's ROE is +0.01%, compared to IWRS's ROE of N/A. Regarding short-term risk, DRSHF is less volatile compared to IWRS. This indicates potentially lower risk in terms of short-term price fluctuations for DRSHF.Check IWRS's competition here